Potential relevance of agmatine as a virulence factor of Helicobacter pylori

Digestive Diseases and Sciences

Volumn 44, Issue 12, 1999, Pages 2397-2404

  Molderings, Gerhard J ^a,b,c   Burian, Maria ^a,b,c   Homann, JÜrgen ^a,b,c   Nilius, Manfred ^a,b,c   Göthert, Manfred ^a,b,c  

^a UNIVERSITY OF BONN   (Germany)

^b EVANGELISCHES KRANKENHAUS   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Agmatine; Gastric juice; Gastrin; Helicobacter pylori; Human

Indexed keywords

AGMATINE; GASTRIN; VIRULENCE FACTOR;

ARTICLE; BACTERIAL VIRULENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GASTRIN BLOOD LEVEL; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; STOMACH JUICE; STOMACH SECRETION;

EID: 0033388445     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026662316750     Document Type: Article

References (40)

1. 1. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness EF, Peterson S, Loftus B, Richardson D, Dodson R, Khaluk HG, Glodek A, McKenney K, Fitzegerald LM, Lee N, Adams MD, Mickey EK, Berg DE, Gocayne JD, Utterback TR, Peterson JD, Kelley JM, Cotton MD, Weidman JM, Fujii C, Bowman C, Watthey L, Wallin E, Hayes WS, Borodovsky M, Karp PD, Smith HO, Fraser CM, Venter JC: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539-547, 1997
2. 2. Cover L, Tummuru MKR, Cao P, Thompson SA, Blaser MJ: Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 269: 10566-10573, 1994
3. 3. Morris DR, Pardee AB: Multiple pathways of putrescine biosynthesis in Eschcrichia coli. J Biol Chem 241:3129-3135, 1966
4. 4. Mercenier A, Simon JP, Haas D, Stalon V: Catabolism of L-arginine by Pseudomonas aeruginosa. J Gen Microbiol 116:381-389, 1980
5. 5. Tabor C, Tabor H: Polyamines in microorganisms. Microbiol Rev 49:81-99, 1985
6. 6. Panagiotidis C, Blackburn S, Low KB, Canellakis ES: Biosynthesis of polyamines in ornithine decarboxylase, arginine decarboxylase, and agmatine ureohydrolase deletion mutants of Escherichia coli strain K-12. Proc Natl Acad Sci USA 48:4423-4427, 1987
7. 7. Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ: Agmatine: An endogenous clonidine-displacing substance in the brain. Science 263:966-969, 1994
8. 8. Raasch W, Regunathan S, Li G, Reis DJ: Agmatine, the bacterial amine, is widely distributed in mammalian tissues. Life Sci 56:2319-2330, 1995
9. 9. Medgett IC, McCulloch MW: Effects of clonidine, guanfacine and three imidazoline derivatives related to clonidine on blood pressure, heart rate and gastric secretion in the anaesthetized rat. Arch Int Pharmacodyn 240:158-168, 1979
10. 10. Del Tacca M, Soldani G, Bernardini C, Martinotti E, Impicciatore M: Pharmacological studies on the mechanisms underlying the inhibitory and excitatory effects of clonidine on gastric acid secretion. Eur J Pharmacol 81:255-261, 1982
11. 11. Bhandare PN, Rataboli PV, D'Souza RSD: Dual action of clonidine on ethanol-induced gastric lesions: Is the imidazoline-preferring receptor involved? Eur J Pharmacol 199:243-245, 1991
12. 12. Glavin GB, Carlisle MA, Smyth DD: Agmatine, an endogenous imidazoline receptors agonist, increases gastric secretion and worsens experimental gastric mucosal injury in rats. J Pharmacol Exp Ther 274:741-744, 1995
13. 13. El-Omar EM, Penman ID, Ardill JES, Chittajallu RS, Howie C, McColl KEL: Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 109:681-691, 1995
14. 14. Konturek PCH, Konturek JW, Konturek SJ: Gastric secretion and the pathogenesis of peptic ulcer in the Helicobacter pylori infection. J Physiol Pharmacol 47:5-19, 1996
15. 15. McGowan CC, Cover TL, Blaser MJ: Helicobacter pylori and gastric acid: Biological and therapeutic implication. Gastroenterology 110:926-938, 1996
16. 16. Laszewicz W, Zarembas-Woroniecka A, Gabryelewicz A: Helicobacter pylori infection and gastric secretion in duodenal and gastric ulcer patients - the effect of eradication after one year. J Physiol Pharmacol 48:353-364, 1997
17. 17. Konturek PC, Konturek SJ, Bobrzynski A, Kwiecien N, Obtulowicz W, Stachura J, Hahn EG, Rembiarz K: Helicobacter pylori and impaired gastric secretory functions associated with duodenal ulcer and atrophic gastritis. J Physiol Pharmacol 48:365-373, 1997
18. 18. Molderings GJ, Göthert M, Homann J, Nilius M: Potential relevance of agmatine for the pathogenesis of gastric mucosal lesions. Naunyn-Schmiedeberg's Arch Pharmacol 357 (suppl):R166, 1998
19. 19. Regunathan S, Feinstein DL, Raasch W, Reis DJ: Agmatine (decarboxylated arginine) is synthesized and stored in astrocytes. Neuroreport 6:1897-1900, 1995
20. 20. Lortie MJ, Novotny WF, Pterson OW, Vallon V, Malvey K, Mendonca M, Satriano J, Insel P, Thomson SC, Blantz RC: Agmatine, a bioactive metabolite of arginine. Production, degradation, and functional effects in the kidney of the rat. J Clin Invest 97:413-420, 1996
21. 21. Courillon-Mallet A, Launay J-M, Roucayrol A-M, Callebert J, Emond J-Ph, Tabuteau F, Cattan D: Helicobacter pylori infection: Physiopathologic implication of Nα-methyl histamine. Gastroenterology 108:959-966, 1995
22. 22. Sobhani I, Bado A, Cherifi Y, Moizo L, Laigneau JP, Pospai D, Mignon M, Lewin MJM: Helicobacter pylori stimulates gastric acid secretion via platelet activating factor. J Physiol Pharmacol 47:177-185, 1996
23. 1, activates protein kinase C and stimulates acid secretion in parietal cells. Prostaglandins Leukot Essent Fatty Acids 59:119-125, 1998
24. 24. Han SR, Schreiber HJ, Bhakdi S, Loos M, Maeurer MJ: VacA genotypes and genetic diversity in clinical isolates of Helicobacter pylori. Clin Diagn Lab Immunol 5:139-145, 1998
25. 25. Berstad K, Berstad A: Helicobacter pylori infection in peptic ulcer disease. Scand J Gastroenterol 28:561-567, 1993
26. 26. Driessen AJM, Smid EJ, Konings WN: Transport of diamines by Enterococcus faecalis is mediated by an agmatine-putrescine antiporter. J Bacteriol 170:4522-4527, 1988
27. 27. Marton LJ, Pegg AE: Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 35:55-91, 1995
28. 28. Sastre M, Regunathan S, Reis DJ: Uptake of agmatine into rat brain synaptosomes: possible role of cation channels. J Neurochem 69:2421-2426, 1997
29. 2-imidazoline and σ binding sites in the rat and human stomach. J Pharmacol Exp Ther 285:170-177, 1998
30. 30. Satriano J, Matsufuji S, Murakami Y, Lortie MJ, Schwanz D, Kelly CJ, Hayashi S, Blantz RC: Agmatine suppresses proliferation by frameshift induction of antizyme and attenuation of cellular polyamine levels. J Biol Chem 273:15313-15316, 1998
31. 31. Galea E, Regunathan S, Eliopoulos V, Feinstein DL, Reis DJ: Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarhoxylation of arginine. Biochem J 316:247-249, 1996
32. 32. Auguet M, Viossat I, Marin JG, Chabrier PE: Selective inhibition of inducible nitric oxide synthase by agmatine. Jpn J Pharmacol 69:285-287, 1995
33. 33. Guslandi M: Nitric oxide: an ubiquitous actor in the gastrointestinal tract. Dig Dis 12:28-36, 1994
34. 34. Schleiffer R, Raul F: Nitric oxide and the digestive system in mammals and non-mammalian vertebrates. Comp Biochem Physiol A Physiol 118:965-974, 1997
35. 35. McColl KEL, El-Omar E: Effect of H. pylori infection on gastrin and gastric acid secretion. In Helicobacter pylori. Basic Mechanisms to Clinical Cure. RH Hunt, GNJ Tytgat (eds). Proceedings, International Symposium, Amelia Island, Florida, November 3-6, 1993, pp 245-256
36. 36. Peterson WL: Gastrin and acid in relation to Helicobacter pylori. Aliment Pharmacol Ther 10(suppl 1):97-102, 1996
37. 2 receptor antagonists on acid secretion stimulated by imidazoline derivatives in isolated parietal cells. Eur J Pharmacol 144:67-76, 1987
38. 38. Seiler N: Pharmacological properties of the natural polyamines and their depletion by biosynthesis inhibitors as a therapeutic approach. Prog Drug Res 37:107-159, 1991
39. 39. Morgan N: Polyamines, arginine and nitric oxide. Biochem Soc Transact 22:879-883, 1994
40. 40. Quik M: Inhibition of nicotinic receptor mediated ion fluxes in rat sympathetic ganglia by BGT II-S1 a potent phospholipase. Brain Res 325:79-88, 1985